![Celldex Therapeutics Inc](/common/images/company/N_CLDX.png)
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more
Melexis Q2 2024 rΓ©sultats β Chiffre d'affaires de 245.7 millions d'euros au deuxiΓ¨me trimestre InformationΒ rΓ©glementΓ©e DΓ©claration intermΓ©diaire par le Conseil d'administrationYpres...
Melexis Q2 2024 results β Second quarter sales of 245.7 million EUR Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - July 31st, 2024, 07.00 hrs CET Dear...
Melexis Q1 2024 rΓ©sultats β Chiffre d'affaires de 241.8 millions d'euros au premier trimestre InformationΒ rΓ©glementΓ©e DΓ©claration intermΓ©diaire par le Conseil d'administrationYpres...
Melexis Q4 et FY 2023 rΓ©sultats β Chiffre d'affaires de 964.3 millions d'euros pour lβensemble de lβannΓ©e InformationΒ rΓ©glementΓ©e DΓ©claration intermΓ©diaire par le Conseil...
Melexis Transparency Notification Press Release - Regulated information -Β Transparency notification Intermediate declaration by the Board of Directors Ypres, Belgium - November 20...
Changes to the Shareholding Structure Press Release - Regulated information - Inside information Intermediate declaration by the Board of Directors Ypres, Belgium - November 14, 2023, 19.00...
Melexis Q3 2023 results β Third quarter sales of 248.6 million EUR Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - October 25th, 2023, 07.00 hrs CET...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.42 | -4.20740740741 | 33.75 | 34.26 | 31.4 | 437416 | 32.88476001 | CS |
4 | -7.24 | -18.2966894112 | 39.57 | 46.86 | 31.4 | 741667 | 37.69831125 | CS |
12 | -5.42 | -14.357615894 | 37.75 | 46.86 | 31.4 | 712374 | 36.66522751 | CS |
26 | -3.52 | -9.81868898187 | 35.85 | 53.18 | 31.4 | 811559 | 40.63498189 | CS |
52 | 2.46 | 8.23568798125 | 29.87 | 53.18 | 22.11 | 741007 | 36.33517382 | CS |
156 | -11.2 | -25.7293820354 | 43.53 | 57.2 | 19.85 | 615206 | 35.74186405 | CS |
260 | 30.16 | 1389.86175115 | 2.17 | 57.2 | 1.5 | 687718 | 26.15212072 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.